{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:39:58Z","timestamp":1792147198377,"version":"4.4.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,1,30]],"date-time":"2012-01-30T00:00:00Z","timestamp":1327881600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1750-9378-7-2","type":"journal-article","created":{"date-parts":[[2012,1,31]],"date-time":"2012-01-31T07:15:28Z","timestamp":1327994128000},"source":"Crossref","is-referenced-by-count":26,"title":["Hepatitis C virus to hepatocellular carcinoma"],"prefix":"10.1186","volume":"7","author":[{"given":"Shah","family":"Jahan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman A","family":"Ashfaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Qasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Khaliq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Javed","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,30]]},"reference":[{"key":"307_CR1","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1002\/hep.1840360704","volume":"36","author":"JH Hoofnagle","year":"2002","unstructured":"Hoofnagle JH: Course and outcome of hepatitis C. Hepatology. 2002, 36: S21-29.","journal-title":"Hepatology"},{"key":"307_CR2","doi-asserted-by":"publisher","first-page":"62S","DOI":"10.1002\/hep.510260711","volume":"26","author":"MJ Alter","year":"1997","unstructured":"Alter MJ: Epidemiology of hepatitis C. Hepatology. 1997, 26: 62S-65S. 10.1002\/hep.510260711.","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"307_CR3","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1038\/sj.cdd.4401121","volume":"10","author":"C Giannini","year":"2003","unstructured":"Giannini C, Brechot C: Hepatitis C virus biology. Cell Death Differ. 2003, 10 (Suppl 1): S27-38.","journal-title":"Cell Death Differ"},{"key":"307_CR4","first-page":"4","volume":"41","author":"NS Raja","year":"2008","unstructured":"Raja NS, Janjua KA: Epidemiology of hepatitis C virus infection in Pakistan. J Microbiol Immunol Infect. 2008, 41: 4-8.","journal-title":"J Microbiol Immunol Infect"},{"key":"307_CR5","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/j.1365-3156.2008.02075.x","volume":"13","author":"UR Khan","year":"2008","unstructured":"Khan UR, Janjua NZ, Akhtar S, Hatcher J: Case-control study of risk factors associated with hepatitis C virus infection among pregnant women in hospitals of Karachi-Pakistan. Trop Med Int Health. 2008, 13: 754-761. 10.1111\/j.1365-3156.2008.02075.x.","journal-title":"Trop Med Int Health"},{"key":"307_CR6","doi-asserted-by":"publisher","first-page":"5080","DOI":"10.3748\/wjg.15.5080","volume":"15","author":"M Idrees","year":"2009","unstructured":"Idrees M, Rafique S, Rehman I, Akbar H, Yousaf MZ, Butt S, Awan Z, Manzoor S, Akram M, Aftab M, et al: Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience. World J Gastroenterol. 2009, 15: 5080-5085. 10.3748\/wjg.15.5080.","journal-title":"World J Gastroenterol"},{"key":"307_CR7","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/sj.bjc.6603649","volume":"96","author":"SA Raza","year":"2007","unstructured":"Raza SA, Clifford GM, Franceschi S: Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer. 2007, 96: 1127-1134. 10.1038\/sj.bjc.6603649.","journal-title":"Br J Cancer"},{"key":"307_CR8","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1128\/JVI.68.8.5063-5073.1994","volume":"68","author":"C Lin","year":"1994","unstructured":"Lin C, Lindenbach BD, Pragai BM, McCourt DW, Rice CM: Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini. J Virol. 1994, 68: 5063-5073.","journal-title":"J Virol"},{"key":"307_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-3-642-59605-6_4","volume":"242","author":"KE Reed","year":"2000","unstructured":"Reed KE, Rice CM: Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol. 2000, 242: 55-84. 10.1007\/978-3-642-59605-6_4.","journal-title":"Curr Top Microbiol Immunol"},{"key":"307_CR10","first-page":"4365","volume":"61","author":"K Moriya","year":"2001","unstructured":"Moriya K, Nakagawa K, Santa T, Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Miyazawa T, Ishibashi K, Horie T, et al: Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res. 2001, 61: 4365-4370.","journal-title":"Cancer Res"},{"key":"307_CR11","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1271\/bbb.60001","volume":"70","author":"M Liu","year":"2006","unstructured":"Liu M, Ding H, Zhao P, Qin ZL, Gao J, Cao MM, Luan J, Wu WB, Qi ZT: RNA interference effectively inhibits mRNA accumulation and protein expression of hepatitis C virus core and E2 genes in human cells. Biosci Biotechnol Biochem. 2006, 70: 2049-2055. 10.1271\/bbb.60001.","journal-title":"Biosci Biotechnol Biochem"},{"key":"307_CR12","doi-asserted-by":"publisher","first-page":"6104","DOI":"10.1073\/pnas.1031527100","volume":"100","author":"D Pavlovic","year":"2003","unstructured":"Pavlovic D, Neville DC, Argaud O, Blumberg B, Dwek RA, Fischer WB, Zitzmann N: The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives. Proc Natl Acad Sci USA. 2003, 100: 6104-6108. 10.1073\/pnas.1031527100.","journal-title":"Proc Natl Acad Sci USA"},{"key":"307_CR13","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S1359-6446(99)01414-2","volume":"4","author":"MA Walker","year":"1999","unstructured":"Walker MA: Hepatitis C virus: an overview of current approaches and progress. Drug Discov Today. 1999, 4: 518-529. 10.1016\/S1359-6446(99)01414-2.","journal-title":"Drug Discov Today"},{"key":"307_CR14","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.mib.2006.06.012","volume":"9","author":"R Bartenschlager","year":"2006","unstructured":"Bartenschlager R: Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture. Curr Opin Microbiol. 2006, 9: 416-422. 10.1016\/j.mib.2006.06.012.","journal-title":"Curr Opin Microbiol"},{"key":"307_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1471-2334-8-69","volume":"8","author":"M Idrees","year":"2008","unstructured":"Idrees M, Riazuddin S: Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis. 2008, 8: 69-10.1186\/1471-2334-8-69.","journal-title":"BMC Infect Dis"},{"key":"307_CR16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0168-8278(00)80166-X","volume":"33","author":"L Rubbia-Brandt","year":"2000","unstructured":"Rubbia-Brandt L, Quadri R, Abid K, Giostra E, Male PJ, Mentha G, Spahr L, Zarski JP, Borisch B, Hadengue A, Negro F: Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol. 2000, 33: 106-115. 10.1016\/S0168-8278(00)80166-X.","journal-title":"J Hepatol"},{"key":"307_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00535-005-1586-z","volume":"40","author":"K Koike","year":"2005","unstructured":"Koike K, Moriya K: Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH. J Gastroenterol. 2005, 40: 329-336. 10.1007\/s00535-005-1586-z.","journal-title":"J Gastroenterol"},{"key":"307_CR18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/0168-8278(95)80108-1","volume":"22","author":"F Farinati","year":"1995","unstructured":"Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, Lecis E, Burra P, Floreani A, Cecchetto A, Naccarato R: Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol. 1995, 22: 449-456. 10.1016\/0168-8278(95)80108-1.","journal-title":"J Hepatol"},{"key":"307_CR19","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jhep.2007.10.011","volume":"48","author":"M Vidali","year":"2008","unstructured":"Vidali M, Tripodi MF, Ivaldi A, Zampino R, Occhino G, Restivo L, Sutti S, Marrone A, Ruggiero G, Albano E, Adinolfi LE: Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C. J Hepatol. 2008, 48: 399-406. 10.1016\/j.jhep.2007.10.011.","journal-title":"J Hepatol"},{"key":"307_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/hep.20032","volume":"39","author":"F Penin","year":"2004","unstructured":"Penin F, Dubuisson J, Rey FA, Moradpour D, Pawlotsky JM: Structural biology of hepatitis C virus. Hepatology. 2004, 39: 5-19. 10.1002\/hep.20032.","journal-title":"Hepatology"},{"key":"307_CR21","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/2053","volume":"4","author":"K Moriya","year":"1998","unstructured":"Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K: The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med. 1998, 4: 1065-1067. 10.1038\/2053.","journal-title":"Nat Med"},{"key":"307_CR22","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1136\/gut.2003.038364","volume":"53","author":"O Nunez","year":"2004","unstructured":"Nunez O, Fernandez-Martinez A, Majano PL, Apolinario A, Gomez-Gonzalo M, Benedicto I, Lopez-Cabrera M, Bosca L, Clemente G, Garcia-Monzon C, Martin-Sanz P: Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins. Gut. 2004, 53: 1665-1672. 10.1136\/gut.2003.038364.","journal-title":"Gut"},{"key":"307_CR23","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1053\/gast.2002.30983","volume":"122","author":"M Okuda","year":"2002","unstructured":"Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, Weinman SA: Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology. 2002, 122: 366-375. 10.1053\/gast.2002.30983.","journal-title":"Gastroenterology"},{"key":"307_CR24","first-page":"715","volume":"2","author":"V Chiarugi","year":"1998","unstructured":"Chiarugi V, Magnelli L, Gallo O: Cox-2, iNOS and p53 as play-makers of tumor angiogenesis (review). Int J Mol Med. 1998, 2: 715-719.","journal-title":"Int J Mol Med"},{"key":"307_CR25","first-page":"1325","volume":"7","author":"MA Rahman","year":"2001","unstructured":"Rahman MA, Dhar DK, Yamaguchi E, Maruyama S, Sato T, Hayashi H, Ono T, Yamanoi A, Kohno H, Nagasue N: Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases. Clin Cancer Res. 2001, 7: 1325-1332.","journal-title":"Clin Cancer Res"},{"key":"307_CR26","first-page":"853","volume":"24","author":"AS Cheng","year":"2004","unstructured":"Cheng AS, Chan HL, To KF, Leung WK, Chan KK, Liew CT, Sung JJ: Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma. Int J Oncol. 2004, 24: 853-860.","journal-title":"Int J Oncol"},{"key":"307_CR27","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.3748\/wjg.v11.i13.1896","volume":"11","author":"TC Tang","year":"2005","unstructured":"Tang TC, Poon RT, Lau CP, Xie D, Fan ST: Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma. World J Gastroenterol. 2005, 11: 1896-1902.","journal-title":"World J Gastroenterol"},{"key":"307_CR28","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1053\/jhep.2003.50380","volume":"38","author":"J Leng","year":"2003","unstructured":"Leng J, Han C, Demetris AJ, Michalopoulos GK, Wu T: Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis. Hepatology. 2003, 38: 756-768.","journal-title":"Hepatology"},{"key":"307_CR29","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrc839","volume":"2","author":"I Vivanco","year":"2002","unstructured":"Vivanco I, Sawyers CL: The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer. 2002, 2: 489-501. 10.1038\/nrc839.","journal-title":"Nat Rev Cancer"},{"key":"307_CR30","doi-asserted-by":"publisher","first-page":"10983","DOI":"10.1073\/pnas.211430998","volume":"98","author":"JR Testa","year":"2001","unstructured":"Testa JR, Bellacosa A: AKT plays a central role in tumorigenesis. Proc Natl Acad Sci USA. 2001, 98: 10983-10985. 10.1073\/pnas.211430998.","journal-title":"Proc Natl Acad Sci USA"},{"key":"307_CR31","doi-asserted-by":"publisher","first-page":"E794","DOI":"10.1152\/ajpendo.00144.2005","volume":"289","author":"MM Assifi","year":"2005","unstructured":"Assifi MM, Suchankova G, Constant S, Prentki M, Saha AK, Ruderman NB: AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved\/carbohydrate-refed rats. Am J Physiol Endocrinol Metab. 2005, 289: E794-800. 10.1152\/ajpendo.00144.2005.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"307_CR32","doi-asserted-by":"publisher","first-page":"8122","DOI":"10.1128\/JVI.00125-07","volume":"81","author":"G Waris","year":"2007","unstructured":"Waris G, Felmlee DJ, Negro F, Siddiqui A: Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. J Virol. 2007, 81: 8122-8130. 10.1128\/JVI.00125-07.","journal-title":"J Virol"},{"key":"307_CR33","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1172\/JCI119248","volume":"99","author":"H Shimano","year":"1997","unstructured":"Shimano H, Horton JD, Shimomura I, Hammer RE, Brown MS, Goldstein JL: Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest. 1997, 99: 846-854. 10.1172\/JCI119248.","journal-title":"J Clin Invest"},{"key":"307_CR34","doi-asserted-by":"publisher","first-page":"7473","DOI":"10.1073\/pnas.96.13.7473","volume":"96","author":"TC Leone","year":"1999","unstructured":"Leone TC, Weinheimer CJ, Kelly DP: A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci USA. 1999, 96: 7473-7478. 10.1073\/pnas.96.13.7473.","journal-title":"Proc Natl Acad Sci USA"},{"key":"307_CR35","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1172\/JCI6223","volume":"103","author":"S Kersten","year":"1999","unstructured":"Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W: Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest. 1999, 103: 1489-1498. 10.1172\/JCI6223.","journal-title":"J Clin Invest"},{"key":"307_CR36","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1046\/j.1365-2893.2001.00316.x","volume":"8","author":"S Pianko","year":"2001","unstructured":"Pianko S, Patella S, Ostapowicz G, Desmond P, Sievert W: Fas-mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection. J Viral Hepat. 2001, 8: 406-413. 10.1046\/j.1365-2893.2001.00316.x.","journal-title":"J Viral Hepat"},{"key":"307_CR37","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1128\/JVI.74.8.3623-3633.2000","volume":"74","author":"L Cocquerel","year":"2000","unstructured":"Cocquerel L, Wychowski C, Minner F, Penin F, Dubuisson J: Charged residues in the transmembrane domains of hepatitis C virus glycoproteins play a major role in the processing, subcellular localization, and assembly of these envelope proteins. J Virol. 2000, 74: 3623-3633. 10.1128\/JVI.74.8.3623-3633.2000.","journal-title":"J Virol"},{"key":"307_CR38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.tim.2005.02.004","volume":"13","author":"KD Tardif","year":"2005","unstructured":"Tardif KD, Waris G, Siddiqui A: Hepatitis C virus, ER stress, and oxidative stress. Trends Microbiol. 2005, 13: 159-163. 10.1016\/j.tim.2005.02.004.","journal-title":"Trends Microbiol"},{"key":"307_CR39","doi-asserted-by":"publisher","first-page":"23077","DOI":"10.1074\/jbc.M100698200","volume":"276","author":"C Bureau","year":"2001","unstructured":"Bureau C, Bernad J, Chaouche N, Orfila C, Beraud M, Gonindard C, Alric L, Vinel JP, Pipy B: Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. J Biol Chem. 2001, 276: 23077-23083. 10.1074\/jbc.M100698200.","journal-title":"J Biol Chem"},{"key":"307_CR40","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1080\/1071576031000102141","volume":"37","author":"S Mahmood","year":"2003","unstructured":"Mahmood S, Yamada G, Niiyama G, Kawanaka M, Togawa K, Sho M, Ito T, Sasagawa T, Okita M, Nakamura H, Yodoi J: Effect of vitamin E on serum aminotransferase and thioredoxin levels in patients with viral hepatitis C. Free Radic Res. 2003, 37: 781-785. 10.1080\/1071576031000102141.","journal-title":"Free Radic Res"},{"key":"307_CR41","first-page":"3171","volume":"54","author":"R Shimoda","year":"1994","unstructured":"Shimoda R, Nagashima M, Sakamoto M, Yamaguchi N, Hirohashi S, Yokota J, Kasai H: Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res. 1994, 54: 3171-3172.","journal-title":"Cancer Res"},{"key":"307_CR42","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1053\/gast.2002.31001","volume":"122","author":"H Lerat","year":"2002","unstructured":"Lerat H, Honda M, Beard MR, Loesch K, Sun J, Yang Y, Okuda M, Gosert R, Xiao SY, Weinman SA, Lemon SM: Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology. 2002, 122: 352-365. 10.1053\/gast.2002.31001.","journal-title":"Gastroenterology"},{"key":"307_CR43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000024973","volume":"42","author":"R Suzuki","year":"1999","unstructured":"Suzuki R, Suzuki T, Ishii K, Matsuura Y, Miyamura T: Processing and functions of Hepatitis C virus proteins. Intervirology. 1999, 42: 145-152. 10.1159\/000024973.","journal-title":"Intervirology"},{"key":"307_CR44","doi-asserted-by":"publisher","first-page":"10771","DOI":"10.1073\/pnas.91.23.10771","volume":"91","author":"MK Shigenaga","year":"1994","unstructured":"Shigenaga MK, Hagen TM, Ames BN: Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA. 1994, 91: 10771-10778. 10.1073\/pnas.91.23.10771.","journal-title":"Proc Natl Acad Sci USA"},{"key":"307_CR45","doi-asserted-by":"publisher","first-page":"8226","DOI":"10.4049\/jimmunol.175.12.8226","volume":"175","author":"SH Lee","year":"2005","unstructured":"Lee SH, Kim YK, Kim CS, Seol SK, Kim J, Cho S, Song YL, Bartenschlager R, Jang SK: E2 of hepatitis C virus inhibits apoptosis. J Immunol. 2005, 175: 8226-8235.","journal-title":"J Immunol"},{"key":"307_CR46","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/0891-5849(96)00131-1","volume":"21","author":"KB Schwarz","year":"1996","unstructured":"Schwarz KB: Oxidative stress during viral infection: a review. Free Radic Biol Med. 1996, 21: 641-649. 10.1016\/0891-5849(96)00131-1.","journal-title":"Free Radic Biol Med"},{"key":"307_CR47","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI774","volume":"101","author":"PL Majano","year":"1998","unstructured":"Majano PL, Garcia-Monzon C, Lopez-Cabrera M, Lara-Pezzi E, Fernandez-Ruiz E, Garcia-Iglesias C, Borque MJ, Moreno-Otero R: Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation. J Clin Invest. 1998, 101: 1343-1352. 10.1172\/JCI774.","journal-title":"J Clin Invest"},{"key":"307_CR48","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/hep.510250340","volume":"25","author":"S Mihm","year":"1997","unstructured":"Mihm S, Fayyazi A, Hartmann H, Ramadori G: Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology. 1997, 25: 735-739. 10.1002\/hep.510250340.","journal-title":"Hepatology"},{"key":"307_CR49","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0168-8278(00)80080-X","volume":"32","author":"C Garcia-Monzon","year":"2000","unstructured":"Garcia-Monzon C, Majano PL, Zubia I, Sanz P, Apolinario A, Moreno-Otero R: Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease. J Hepatol. 2000, 32: 331-338. 10.1016\/S0168-8278(00)80080-X.","journal-title":"J Hepatol"},{"key":"307_CR50","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1093\/carcin\/20.7.1337","volume":"20","author":"B Ahn","year":"1999","unstructured":"Ahn B, Han BS, Kim DJ, Ohshima H: Immunohistochemical localization of inducible nitric oxide synthase and 3-nitrotyrosine in rat liver tumors induced by N-nitrosodiethylamine. Carcinogenesis. 1999, 20: 1337-1344. 10.1093\/carcin\/20.7.1337.","journal-title":"Carcinogenesis"},{"key":"307_CR51","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1053\/gast.2001.20875","volume":"120","author":"M Jaiswal","year":"2001","unstructured":"Jaiswal M, LaRusso NF, Shapiro RA, Billiar TR, Gores GJ: Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes. Gastroenterology. 2001, 120: 190-199. 10.1053\/gast.2001.20875.","journal-title":"Gastroenterology"},{"key":"307_CR52","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1172\/JCI13271","volume":"107","author":"WL Smith","year":"2001","unstructured":"Smith WL, Langenbach R: Why there are two cyclooxygenase isozymes. J Clin Invest. 2001, 107: 1491-1495. 10.1172\/JCI13271.","journal-title":"J Clin Invest"},{"key":"307_CR53","doi-asserted-by":"publisher","first-page":"7384","DOI":"10.1073\/pnas.89.16.7384","volume":"89","author":"T Hla","year":"1992","unstructured":"Hla T, Neilson K: Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA. 1992, 89: 7384-7388. 10.1073\/pnas.89.16.7384.","journal-title":"Proc Natl Acad Sci USA"},{"key":"307_CR54","doi-asserted-by":"crossref","first-page":"9049","DOI":"10.1016\/S0021-9258(18)52976-8","volume":"268","author":"DA Jones","year":"1993","unstructured":"Jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM: Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem. 1993, 268: 9049-9054.","journal-title":"J Biol Chem"},{"key":"307_CR55","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/hep.510290355","volume":"29","author":"H Koga","year":"1996","unstructured":"Koga H, Sakisaka M, Ohishi T, Kawaquchi E, Taniquchi K, Sasatomi M, Harada T, Kusaba M, Tanaka R, Kimura Y, et al: Expression of cyclooxygenase- 2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology. 1996, 29: 688-696.","journal-title":"Hepatology"},{"key":"307_CR56","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1517\/14728222.6.4.483","volume":"6","author":"MA Rahman","year":"2002","unstructured":"Rahman MA, Kohno H, Nagasue N: COX-2-a target for preventing hepatic carcinoma?. Expert Opin Ther Targets. 2002, 6: 483-490. 10.1517\/14728222.6.4.483.","journal-title":"Expert Opin Ther Targets"},{"key":"307_CR57","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/jcp.20560","volume":"207","author":"C Han","year":"2006","unstructured":"Han C, Michalopoulos GK, Wu T: Prostaglandin E2 receptor EP1 transactivates EGFR\/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells. J Cell Physiol. 2006, 207: 261-270. 10.1002\/jcp.20560.","journal-title":"J Cell Physiol"},{"key":"307_CR58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/sj.neo.7900127","volume":"3","author":"O Gallo","year":"2001","unstructured":"Gallo O, Franchi A, Magnelli L, Sardi I, Vannacci A, Boddi V, Chiarugi V, Masini E: Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. Neoplasia. 2001, 3: 53-61. 10.1038\/sj.neo.7900127.","journal-title":"Neoplasia"},{"key":"307_CR59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1749-0774.2002.tb00095.x","volume":"15","author":"H Amano","year":"2002","unstructured":"Amano H, Haysahi I, Yoshida S, Yoshimura H, Majima M: Cyclooxygenase-2 and adenylate cyclase\/protein kinase A signaling pathway enhances angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Hum Cell. 2002, 15: 13-24. 10.1111\/j.1749-0774.2002.tb00095.x.","journal-title":"Hum Cell"},{"key":"307_CR60","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.cardiores.2005.09.019","volume":"69","author":"G Wu","year":"2006","unstructured":"Wu G, Luo J, Rana JS, Laham R, Sellke FW, Li J: Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells. Cardiovasc Res. 2006, 69: 512-519. 10.1016\/j.cardiores.2005.09.019.","journal-title":"Cardiovasc Res"},{"key":"307_CR61","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, et al: Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001, 108: 1167-1174.","journal-title":"J Clin Invest"},{"key":"307_CR62","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0092-8674(95)90127-2","volume":"83","author":"M Tsujii","year":"1995","unstructured":"Tsujii M, DuBois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell. 1995, 83: 493-501. 10.1016\/0092-8674(95)90127-2.","journal-title":"Cell"},{"key":"307_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0968-0004(96)20031-3","volume":"22","author":"EA Dennis","year":"1997","unstructured":"Dennis EA: The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem Sci. 1997, 22: 1-2. 10.1016\/S0968-0004(96)20031-3.","journal-title":"Trends Biochem Sci"},{"key":"307_CR64","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev.pharmtox.39.1.175","volume":"39","author":"J Balsinde","year":"1999","unstructured":"Balsinde J, Balboa MA, Insel PA, Dennis EA: Regulation and inhibition of phospholipase A2. Annu Rev Pharmacol Toxicol. 1999, 39: 175-189. 10.1146\/annurev.pharmtox.39.1.175.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"307_CR65","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/carcin\/bgi022","volume":"26","author":"R Mayoral","year":"2005","unstructured":"Mayoral R, Fernandez-Martinez A, Bosca L, Martin-Sanz P: Prostaglandin E2 promotes migration and adhesion in hepatocellular carcinoma cells. Carcinogenesis. 2005, 26: 753-761. 10.1093\/carcin\/bgi022.","journal-title":"Carcinogenesis"},{"key":"307_CR66","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1053\/jhep.2002.32676","volume":"35","author":"S Abiru","year":"2002","unstructured":"Abiru S, Nakao K, Ichikawa T, Migita K, Shigeno M, Sakamoto M, Ishikawa H, Hamasaki K, Nakata K, Eguchi K: Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells. Hepatology. 2002, 35: 1117-1124. 10.1053\/jhep.2002.32676.","journal-title":"Hepatology"},{"key":"307_CR67","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1053\/gast.2001.29691","volume":"121","author":"F Cianchi","year":"2001","unstructured":"Cianchi F, Cortesini C, Bechi P, Fantappie O, Messerini L, Vannacci A, Sardi I, Baroni G, Boddi V, Mazzanti R, Masini E: Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer. Gastroenterology. 2001, 121: 1339-1347. 10.1053\/gast.2001.29691.","journal-title":"Gastroenterology"},{"key":"307_CR68","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1074\/jbc.M108798200","volume":"277","author":"RG Hope","year":"2002","unstructured":"Hope RG, Murphy DJ, McLauchlan J: The domains required to direct core proteins of hepatitis C virus and GB virus-B to lipid droplets share common features with plant oleosin proteins. J Biol Chem. 2002, 277: 4261-4270. 10.1074\/jbc.M108798200.","journal-title":"J Biol Chem"},{"key":"307_CR69","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000007814","volume":"62","author":"I Emerit","year":"2000","unstructured":"Emerit I, Serejo F, Filipe P, Alaoui Youssefi A, Fernandes A, Costa A, Freitas J, Ramalho F, Baptista A, Carneiro de Moura M: Clastogenic factors as biomarkers of oxidative stress in chronic hepatitis C. Digestion. 2000, 62: 200-207. 10.1159\/000007814.","journal-title":"Digestion"},{"key":"307_CR70","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jhep.2004.12.034","volume":"42","author":"K Abid","year":"2005","unstructured":"Abid K, Pazienza V, de Gottardi A, Rubbia-Brandt L, Conne B, Pugnale P, Rossi C, Mangia A, Negro F: An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation. J Hepatol. 2005, 42: 744-751. 10.1016\/j.jhep.2004.12.034.","journal-title":"J Hepatol"},{"key":"307_CR71","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/gut.2004.050302","volume":"54","author":"L Fartoux","year":"2005","unstructured":"Fartoux L, Poujol-Robert A, Guechot J, Wendum D, Poupon R, Serfaty L: Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut. 2005, 54: 1003-1008. 10.1136\/gut.2004.050302.","journal-title":"Gut"},{"key":"307_CR72","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1002\/cncr.22701","volume":"109","author":"JR Pekow","year":"2007","unstructured":"Pekow JR, Bhan AK, Zheng H, Chung RT: Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer. 2007, 109: 2490-2496. 10.1002\/cncr.22701.","journal-title":"Cancer"},{"key":"307_CR73","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.virol.2004.11.009","volume":"332","author":"I Bieche","year":"2005","unstructured":"Bieche I, Asselah T, Laurendeau I, Vidaud D, Degot C, Paradis V, Bedossa P, Valla DC, Marcellin P, Vidaud M: Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. Virology. 2005, 332: 130-144. 10.1016\/j.virol.2004.11.009.","journal-title":"Virology"},{"key":"307_CR74","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0168-8278(02)00299-4","volume":"37","author":"J Westin","year":"2002","unstructured":"Westin J, Nordlinder H, Lagging M, Norkrans G, Wejstal R: Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients. J Hepatol. 2002, 37: 837-842. 10.1016\/S0168-8278(02)00299-4.","journal-title":"J Hepatol"},{"key":"307_CR75","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1136\/gut.2003.018770","volume":"53","author":"L Rubbia-Brandt","year":"2004","unstructured":"Rubbia-Brandt L, Fabris P, Paganin S, Leandro G, Male PJ, Giostra E, Carlotto A, Bozzola L, Smedile A, Negro F: Steatosis affects chronic hepatitis C progression in a genotype specific way. Gut. 2004, 53: 406-412. 10.1136\/gut.2003.018770.","journal-title":"Gut"},{"key":"307_CR76","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jhep.2003.11.004","volume":"40","author":"HM Patton","year":"2004","unstructured":"Patton HM, Patel K, Behling C, Bylund D, Blatt LM, Vallee M, Heaton S, Conrad A, Pockros PJ, McHutchison JG: The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients. J Hepatol. 2004, 40: 484-490.","journal-title":"J Hepatol"},{"key":"307_CR77","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1365-2893.2004.00528.x","volume":"11","author":"C Hezode","year":"2004","unstructured":"Hezode C, Roudot-Thoraval F, Zafrani ES, Dhumeaux D, Pawlotsky JM: Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections. J Viral Hepat. 2004, 11: 455-458. 10.1111\/j.1365-2893.2004.00528.x.","journal-title":"J Viral Hepat"},{"key":"307_CR78","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.2337\/diabetes.50.5.1102","volume":"50","author":"R Halse","year":"2001","unstructured":"Halse R, Pearson SL, McCormack JG, Yeaman SJ, Taylor R: Effects of tumor necrosis factor-alpha on insulin action in cultured human muscle cells. Diabetes. 2001, 50: 1102-1109. 10.2337\/diabetes.50.5.1102.","journal-title":"Diabetes"},{"key":"307_CR79","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/39335","volume":"389","author":"KT Uysal","year":"1997","unstructured":"Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS: Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature. 1997, 389: 610-614. 10.1038\/39335.","journal-title":"Nature"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-9378-7-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1750-9378-7-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-9378-7-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T10:16:47Z","timestamp":1640600207000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/1750-9378-7-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,30]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["307"],"URL":"https:\/\/doi.org\/10.1186\/1750-9378-7-2","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,30]]},"article-number":"2"}}